Renovaro rebrands as Lunai Bioworks Inc. (NASDAQ: RENB) name change

Rhea-AI Filing Summary

Renovaro Inc. reported that it has amended its Restated Certificate of Incorporation to change its corporate name to Lunai Bioworks Inc. The amendment was filed in Delaware on August 18, 2025, and the name change became effective on August 20, 2025.

The company’s common stock will continue to trade on Nasdaq under the ticker symbol RENB, although the CUSIP number for the common stock will change as a result of the new name. The company also includes forward-looking statements about plans to hold its annual meeting and regain compliance with Nasdaq listing standards.

false --06-30 0001527728 0001527728 2025-08-26 2025-08-26 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 26, 2025

RENOVARO INC.

(Exact name of registrant as specified in its charter)

Delaware		001-38751		45-2259340
(State or other jurisdiction		(Commission File Number)		(I.R.S. Employer
of incorporation)				Identification No.)

2080 Century Park East, Suite 906

Los Angeles, CA 90067

 (Address of principal executive offices)

+1 (305) 918-1980

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class		Trading Symbol		Name of Each Exchange on Which Registered
Common Stock, par value $0.0001 per share		RENB		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On August 18, 2025, Renovaro Inc. (the “Company”) filed a Certificate of Amendment to its Restated Certificate of Incorporation with the Secretary of State of the State of Delaware to change its corporate name from ”Renovaro Inc.” to ”Lunai Bioworks Inc.” (the “Name Change”). The Name Change became effective on August 20, 2025.

The Company’s common stock will continue to trade on the Nasdaq under the ticker symbol RENB, although the CUSIP number for the common stock will be changed as a result of the Name Change.

A copy of the Certificate of Amendment as filed with the Secretary of State of the State of Delaware is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

Exhibit No.		Description
3.1		Certificate of Amendment to the Restated Certificate of Incorporation of Renovaro Inc., dated August 18, 2025 (Name Change)

Forward-Looking Statements

This Current Report on Form 8-K contains forward-looking statements, including statements regarding the Company’s plans to hold its annual meeting and regain compliance with Nasdaq listing standards. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s control, and actual results may differ materially from those described in such statements. Readers are cautioned not to place undue reliance on these forward-looking statements.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	RENOVARO INC.
	By:	/s/ David Weinstein
		Name: David Weinstein Title: Chief Executive Officer

Date: August 26, 2025

FAQ

What corporate change did Renovaro Inc. (RENB) disclose in this 8-K?

The company disclosed that it amended its Restated Certificate of Incorporation to change its corporate name from "Renovaro Inc." to "Lunai Bioworks Inc.".

When did the Lunai Bioworks Inc. name change become effective for RENB?

The name change from Renovaro Inc. to Lunai Bioworks Inc. became effective on August 20, 2025.

Does Renovaro Inc. (RENB) change its Nasdaq ticker symbol after the name change?

No. The company states that its common stock will continue to trade on Nasdaq under the ticker symbol RENB, even after the name change to Lunai Bioworks Inc.

What happens to the CUSIP for RENB common stock after the name change?

The company notes that the CUSIP number for its common stock will be changed as a result of the name change to Lunai Bioworks Inc.

What document implements the name change for Renovaro Inc. (RENB)?

The name change is implemented through a Certificate of Amendment to the Restated Certificate of Incorporation, filed with the Delaware Secretary of State on August 18, 2025.

What forward-looking plans does Renovaro Inc. (RENB) mention in this filing?

The company includes forward-looking statements about its plans to hold its annual meeting and regain compliance with Nasdaq listing standards.

Who signed the 8-K reporting the name change for Renovaro Inc. (RENB)?

The report was signed on behalf of the company by David Weinstein, who is identified as the Chief Executive Officer.